NCT02481336View on ClinicalTrials.gov

To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Neurotoxicity Syndromes
Interventions
OTHER

Questionnaires

EORTC CIPN20 and EQ-5D-3L

PROCEDURE

Peripheral nervous system examination

nerve conduction velocity (NCV), quantitative sensory test (QST), and nerve excitability test (NET)

GENETIC

Whole Genome Sequence

Genetic Test : 10 mL blood will be collected in Blood Sample Collection

Trial Locations (1)

704

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER

NCT02481336 - To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity | Biotech Hunter | Biotech Hunter